Nanos Homolog 1 antibody (C-Term)

Catalog No. ABIN185370

This anti-Nanos Homolog 1 antibody is a Goat Polyclonal antibody detecting Nanos Homolog 1 in WB and ELISA. Suitable for Human.

Quick Overview for Nanos Homolog 1 antibody (C-Term) (ABIN185370)

Target: Nanos Homolog 1 (NANOS1)

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This Nanos Homolog 1 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Grade: Verified

Product Details anti-Nanos Homolog 1 Antibody

Binding Specificity: C-Term

Purpose: NANOS1

Sequence: SARDGPPGKK LR

Cross-Reactivity: Human

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogen: Peptide with sequence C-SARDGPPGKKLR, from the C Terminus of the protein sequence according to NP_955631.1.

Isotype: IgG

Application Details

Application Notes:

Western Blot: Approx 35-37 kDa band observed in Human Testis lysates (calculated MW of 30.2 kDa according to NP_955631.1). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Clarke et al, Hum Mol Genet.

Peptide ELISA: antibody detection limit dilution 1:64000.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Minimize freezing and thawing.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Target Details for Nanos Homolog 1

Target: Nanos Homolog 1 (NANOS1)

Alternative Name: NANOS1

Background: NANOS1, nanos homolog 1 (Drosophila), NOS1, nanos homolog 1

Gene ID: 340719

NCBI Accession: NP_955631

Pathways: Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction